Femoral frACturEs and COVID-19.

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio140 enrolled

Overview

Retrospective cohort study comparing the early prognosis after surgically-treated proximal femur fragility fractures in patients affected and not affected by COVID-19.

Study Type

OBSERVATIONAL

Enrollment

140

Conditions

Covid19 Femur Fracture Fragility Fracture

Interventions

COVID-19OTHER

Patients affected versus not affected by COVID-19, with the same starting condition (proximal femur fracture)

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥45 years * Admitted to IRCCS Orthopaedic Institute Galeazzi for proximal femur fractures from march 2020 to april 2020. * Tested for COVID-19 through naso-pharyngeal swab analized with RT-PCR Exclusion Criteria: * Age \<45 years * Not tested for SARS-CoV-2 * Other fractures (including bilateral proximal femur fractures)

Locations (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, Italy

RECRUITING

Outcomes

Primary Outcomes

Survival at discharge day (comparison between the two groups)

Time frame: on discharge day, on average after 1 week

Secondary Outcomes

Length of stay (comparison between the two groups)

Time frame: on discharge day, on average 1 week

Readmission rate (comparison between the two groups)

Time frame: up to 30 days after discharge

Complications rate (comparison between the two groups)

Time frame: up to 30 days after discharge

Survival at 30 days after discharge (comparison between the two groups)

Time frame: 30 days after discharge

Routine lab exams values (comparison between the two groups)

Time frame: At admission, 1st postoperative day, 5th postoperative day, on discharge day

Central Contacts

Giuseppe M Peretti, MD

CONTACT

0039 3396610282 giuseppe.peretti@unimi.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.